CVR number 37837466
Industry 75.0000 Veterinary activities

Espergærde Dyreklinik ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.2% 5.6% 4.9% 4.2% 5.6%  
Credit score (0-100)  43 39 43 48 41  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  5,114 5,208 5,380 5,532 6,125  
EBITDA  565 1,632 1,723 1,427 1,996  
EBIT  330 1,378 1,454 1,160 1,756  
Pre-tax profit (PTP)  324.2 1,373.8 1,446.3 1,159.9 1,760.6  
Net earnings  252.4 1,070.1 1,125.8 900.5 1,367.3  
Pre-tax profit without non-rec. items  324 1,374 1,446 1,160 1,761  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  319 426 308 241 152  
Shareholders equity total  1,434 1,754 1,880 1,780 2,147  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,029 2,687 2,714 2,737 3,330  
Net Debt  -2,253 -1,066 -1,417 -1,542 -2,444  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,114 5,208 5,380 5,532 6,125  
Gross profit growth  8.7% 1.8% 3.3% 2.8% 10.7%  
Employees  7 8 9 10 10  
Employee growth %  0.0% 14.3% 12.5% 11.1% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,029 2,687 2,714 2,737 3,330  
Balance sheet change%  29.5% -33.3% 1.0% 0.9% 21.6%  
Added value  564.7 1,632.3 1,723.1 1,428.8 1,996.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -394 -298 -538 -486 -480  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  6.5% 26.5% 27.0% 21.0% 28.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.4% 41.3% 53.9% 42.6% 58.2%  
ROI %  18.4% 78.6% 74.6% 60.4% 87.6%  
ROE %  15.7% 67.1% 62.0% 49.2% 69.6%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  35.6% 65.3% 69.3% 65.0% 64.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -399.1% -65.3% -82.2% -108.1% -122.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  51.6% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.1 1.6 2.1 1.9 2.2  
Current Ratio  1.2 2.1 2.7 2.5 2.6  
Cash and cash equivalent  2,253.4 1,065.5 1,417.0 1,542.3 2,443.8  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  544.6 876.9 1,230.8 1,307.4 1,874.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  81 204 191 143 200  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  81 204 191 143 200  
EBIT / employee  47 172 162 116 176  
Net earnings / employee  36 134 125 90 137